Chad Messer
Stock Analyst at Lake Street
(0.70)
# 3,983
Out of 4,981 analysts
27
Total ratings
40.74%
Success rate
-20.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.32 | +1,309.77% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $1.24 | +464.52% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $5.63 | +184.19% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.81 | +556.17% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $9.46 | +143.13% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $2.20 | +763.64% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $2.78 | +4,000.72% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $55.07 | -9.21% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $49.44 | -2.91% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $39.01 | -23.10% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $40.22 | +24.32% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $12.65 | +129.25% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.76 | +468.18% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $61.10 | +40.75% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $3.62 | +1,971.82% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $8.67 | +407.50% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $17.47 | +850.20% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $2.92 | +516.44% | 1 | May 5, 2020 |
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.32
Upside: +1,309.77%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.24
Upside: +464.52%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $5.63
Upside: +184.19%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.81
Upside: +556.17%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $9.46
Upside: +143.13%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $2.20
Upside: +763.64%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $2.78
Upside: +4,000.72%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $55.07
Upside: -9.21%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $49.44
Upside: -2.91%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $39.01
Upside: -23.10%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $40.22
Upside: +24.32%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $12.65
Upside: +129.25%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.76
Upside: +468.18%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $61.10
Upside: +40.75%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $3.62
Upside: +1,971.82%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $8.67
Upside: +407.50%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $17.47
Upside: +850.20%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $2.92
Upside: +516.44%